Jefferies analyst Joe Dickstein initiated coverage of American Healthcare REIT (AHR) with a Buy rating and $37 price target The company’s focus on high acuity senior housing positions it as one of the cleanest ways to invest in the aging demographics theme, the analyst tells investors in a research note. The firm believes the stock’s premium multiple can expand further as it forecasts 13% annual earnings growth over the next three years, or the second highest in the peer group.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target lowered to $34 from $35 at KeyBanc
- American Healthcare REIT price target raised to $37 from $36 at Morgan Stanley
- American Healthcare REIT management to meet with KeyBanc
- American Healthcare REIT Announces Quarterly Distribution
- American Healthcare REIT price target raised to $32 from $30 at Truist